Source: Emily Kopp, ROLL CALL, 10/15/21

Advisers to the Food and Drug Administration voted, 19-0, to authorize a Johnson & Johnson COVID-19 booster shot at least two months after the first dose, providing some reassurance to the 14 million Americans who received its vaccine and face a higher risk of mild cases than other vaccinated people. The Vaccines and Related Biological Products Advisory Committee recommended the second shot after parsing the data for five hours.

For more of this story, click here.